Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocCheck AGFRA:AJ91 +0.87%71 Days Payable is 48.41 as of Dec. 2025, which is 18% above its 10-year median of 40.94. GuruFocus rates FRA:AJ91 with a GF Score™ of 71/100 and a GF Value™ of €9.28 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 607 Healthcare Providers & Services companies, DocCheck AG ranks worse than 53.87% on this metric.
The historical rank and industry rank for DocCheck AG's Days Payable or its related term are showing as below:
FRA:AJ91'
s Days Payable Range Over the Past 10 Years
Min: 13.88 Med: 40.94 Max: 54.9
Current: 52.27
During the past 13 years, DocCheck AG's highest Days Payable was 54.90. The lowest was 13.88. And the median was 40.94.
FRA:AJ91's Days Payable is ranked worse than 53.87% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs FRA:AJ91: 52.27
DocCheck AG's Days Payable
increased
from Dec. 2024 (39.15) to Dec. 2025 (48.41).
It may suggest that DocCheck AGdelayed paying its suppliers.
DocCheck AG Days Payable Related Terms
DocCheck AG Days Payable Historical Data
* Premium members only.
The historical data trend for DocCheck AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:AJ91 vs VEEV, BTSG, TEM: Days Payable Comparison
For the Health Information Services subindustry, DocCheck AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocCheck AG Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's Days Payable distribution charts can be found below:
* The bar in red indicates where DocCheck AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
DocCheck AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocCheck AG (FRA:AJ91) has a Days Payable of 48.41 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on DocCheck AG and its competitors. This is 18% above median its historical median of 40.94. Over the past decade, DocCheck AG's Days Payable has ranged from 13.88 to 54.90. According to the industry distribution chart, DocCheck AG ranks #327 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 53.9%.
Is DocCheck AG's Days Payable too high?
DocCheck AG's current Days Payable of 48.41 is 18% above median its 10-year median of 40.94. Over the past 10 years, this metric has ranged from a low of 13.88 to a high of 54.90. The Healthcare Providers & Services industry median Days Payable is 57.13. DocCheck AG's value of 48.41 is 15.3% below this industry median. Based on the distribution chart, DocCheck AG ranks #327 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, DocCheck AG has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DocCheck AG's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DocCheck AG ranks #327 out of 607 companies for Days Payable. This places DocCheck AG in the lower half of its industry. The industry median Days Payable is 57.13. DocCheck AG's value of 48.41 is 15.3% below this benchmark. Historically, DocCheck AG's own Days Payable has ranged from 13.88 to 54.90 over the past decade. While the company's 10-year median is 40.94 vs. the industry median of 57.13, DocCheck AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocCheck AG's current Days Payable of 48.41 is 15.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on DocCheck AG and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocCheck AG's current Days Payable is 48.41, which is 18% above median its own 10-year median of 40.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocCheck AG stock overvalued right now?
Based on GuruFocus' analysis, DocCheck AG (FRA:AJ91) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.28, compared to a current price of €11.60 — trading 25% above its estimated fair value. The current Days Payable is 48.41, which is 18% above median its 10-year median of 40.94 and 15.3% below the Healthcare Providers & Services industry median of 57.13. DocCheck AG's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For DocCheck AG (FRA:AJ91), the current Days Payable is 48.41 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocCheck AG (FRA:AJ91) Overvalued in 2026?
Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued.
The current stock price of €11.60 is trading 25% above its estimated GF Value™ of €9.28.
GuruFocus considers DocCheck AG to be Modestly Overvalued.
Key valuation signals for FRA:AJ91:
Days Payable: 48.41 (18% above median its 10-year median of 40.94)
GF Value™: €9.28 vs. price of €11.60 (25% above fair value)
Industry Position: 15.3% below the Healthcare Providers & Services median (#327 of 607)
No single metric tells the full story. See the FRA:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score
Get the complete analysis for FRA:AJ91
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AJ91 has been successfully added to your 
